Trial Profile
The dopaminergic system in schizotypal personality disorder: pergolide for cognitive symptoms in schizotypal personality disorder
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Pergolide (Primary)
- Indications Personality disorders
- Focus Therapeutic Use
- 20 Jan 2006 New trial record.